Logo for LaunchBio Program: WebinarsLogo for LaunchBio Program: Webinars

Connecting biotech entrepreneurs, industry, and researchers with knowledge, captial, and talent

Online

Beyond the Pitch Deck

Informal strategies to maximize impact at JPM

Program

The JPMorgan Healthcare Conference (JPM) is not just about delivering a polished pitch deck — it’s about sharing your story, establishing meaningful connections, managing time well, and uncovering opportunities with every interaction. In this roundtable discussion, we will move beyond the usual presentation mechanics to explore strategies to maximize your presence at the industry’s largest event.

Panel 1

Learn how to navigate JPM with intentional networking that fosters genuine partnerships while making time in your schedule for these moments of serendipity that could lead to big opportunities. Staying sharp and present can be your greatest advantage, so we will discuss managing mental and physical energy throughout the fast-paced week. We will also explore the significance of maintaining a personal brand that shines in every interaction and leaves a lasting impact and how to continue building that brand after the conference.

Whether you’re a founder, investor, or industry professional, this webinar will provide actionable strategies that go beyond the usual advice, helping you approach the conference with confidence, clarity, and purpose.

Join us for a real, no-frills conversation on what it takes to make the most of JPM.

Webinar attendees will receive first access to our invite-only Innovator Social Hour during JPM week in January 2025.

Speakers

  • Stephen Perry, Founder and CEO, Kymanox

    Stephen Perry, Founder and CEO, Kymanox

    Stephen M. Perry is the CEO and Founder of Kymanox—a diversified and global professional services company solely focused on the Pharmaceutical, Biotechnology, Medical Device, and Combination Product industries. He has extensive CGxP experience as a Process Engineer, Technical Project Manager, Quality Auditor, and Regulatory Strategist. As a business executive, Stephen has successfully attracted growth capital from WestView Capital Partners and has further grown the unique Kymanox platform with the acquisition of four different companies.

  • Tyler Mizenko

    Tyler Mizenko, MBA, Chief Revenue Officer, Prendio-BioProcure

    Tyler Mizenko is the Chief Revenue Officer at Prendio-BioProcure, where he leads the go-to-market strategy and oversees the company’s global sales efforts, alliances, and partnerships. Tyler has played a pivotal role in building and scaling Prendio-BioProcure sales strategy and execution while providing crucial support to the executive leadership team. He has been instrumental in negotiating and executing partnerships with leading global life science suppliers and the Venture Capital firms that Prendio-BioProcure collaborates with today.

  • Jill Collins

    Jill Collins, PhD, CEO + Chief Strategy Officer, Audacity Health

    Jill has over 20 years of experience in scientific marketing and business development. With a background in medicinal chemistry and postdoctoral work in neuroscience, she transitioned into strategic roles in biotech, focusing on immunoassays, diagnostics, and precision oncology. At Audacity, she drives branding and commercial strategies for life science, diagnostic, and biopharma companies.